BILI
Bilibili Inc
14.90$
-0.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 55.3% | 56.5% | 53.3% | 55.9% | 58.4% | 60.4% | 61.8% | 65.9% | 67.6% | 66.9% | 66.8% | 66.3% | |
| 22.5% | 21.7% | 20.0% | 11.9% | 23.3% | 31.3% | 28.9% | 27.5% | 30.3% | 29.7% | 15.9% | 12.2% | |
| 42.8% | 45.6% | 42.7% | 44.4% | 47.6% | 51.0% | 52.7% | 57.5% | 58.8% | 58.8% | 58.4% | 57.2% | |
| 4.9% | 4.7% | 4.2% | 5.1% | 4.7% | 3.8% | 3.0% | 5.6% | 2.8% | 3.1% | 3.2% | 4.0% | |
| 0.5% | 0.7% | 0.2% | 0.7% | – | 0.9% | 0.9% | 0.5% | – | 0.5% | – | – | |
| 2.4% | – | – | – | – | – | – | – | – | – | – | – | |
| 8.0% | 8.2% | 9.0% | 8.7% | 8.5% | 8.3% | 8.2% | 7.0% | 6.8% | 6.8% | 6.8% | 6.6% | |
| 11.5% | 10.9% | 11.5% | 10.9% | 10.1% | 9.8% | 9.6% | 7.8% | 7.4% | 7.6% | 7.4% | 6.8% | |
| 54.3% | 56.6% | 54.0% | 56.6% | 57.1% | 56.9% | 56.8% | 63.5% | 62.7% | 62.2% | 62.3% | 62.5% | |
| 43.3% | 54.6% | 52.0% | 54.8% | 55.5% | 45.1% | 45.4% | 41.3% | 41.3% | 49.4% | 49.7% | 50.4% | |
| 13.2% | 23.1% | 16.3% | 15.5% | 13.4% | 5.5% | 6.1% | 5.0% | 4.1% | 11.8% | 11.7% | 11.5% | |
| 12.2% | 13.1% | 15.0% | 14.6% | 15.4% | 14.7% | 15.0% | 14.0% | 13.3% | 13.4% | 14.4% | 14.8% | |
| 9.1% | 0.0% | 0.0% | 0.0% | 0.0% | 10.0% | 9.8% | 20.9% | 20.2% | 11.6% | 11.4% | 10.9% | |
| 45.6% | 43.4% | 46.0% | 43.4% | 42.9% | 43.1% | 43.2% | 36.5% | 37.3% | 37.8% | 37.8% | 37.6% | |
| -77.6% | -79.2% | -91.5% | -88.3% | – | -84.4% | -83.0% | -70.8% | – | -64.3% | – | – | |
| 1.2% | 1.3% | 1.4% | 1.3% | 1.3% | 1.3% | 1.3% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.